Your session is about to expire
← Back to Search
Behavioral Intervention
EMPOWER-Latinx for Caregivers
N/A
Waitlist Available
Led By Rosairo Costas Muniz, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will investigate if a wellness program can help reduce stress in Latinx ICU caregivers.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
feasibility of EMPOWER-Latinx
Trial Design
1Treatment groups
Experimental Treatment
Group I: EMPOWER-Latinx interventionExperimental Treatment1 Intervention
Informal caregivers will meet with the interventionist one-on-one via telepsychiatry (e.g., WebEx, Zoom) for 6, 15-20 minute modules to be completed within about 2-3 days from initiation of the first module, not including the booster modules. Informal caregivers will complete study assessments as per the schedule of assessments.
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,934 Previous Clinical Trials
588,810 Total Patients Enrolled
Rosairo Costas Muniz, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
Wendy Lichtenthal, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
7 Previous Clinical Trials
1,278 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Caregivers who have been evaluated as being at risk for suicide based on the Columbia Suicide Severity Rating Scale will be excluded.
Research Study Groups:
This trial has the following groups:- Group 1: EMPOWER-Latinx intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the participant enrollment count for this experiment?
"Affirmative. The clinicaltrials.gov website contains proof that this trial, initially posted on October 18th 2022, is currently recruiting candidates. In total, 10 participants are sought by the researchers at a single medical centre."
Answered by AI
Are there current openings for participation in this clinical research?
"Concurrently, clinicaltrials.gov confirms that volunteers for this trial are being sought after. This medical study was initially posted on October 18th 2022 and its information was last refreshed on December 7th 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger